Citations 2
Treatment-free remission (TFR) in patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP) treated with second-line nilotinib (NIL): First results from the ENESTop study.
Boquimpani, Carla , Kim, Dong‐Wook , Benyamini, Noam , Clementino, Nelma Cristina D., Arias, Raquel De Paz, Moiraghi, Beatriz, Nicolini, Franck E., Dengler, Jolanta, Sacha, Tomasz , Takahashi, Naoto , Fellague-Chebra, Rafik, Acharya, Sandip, Wong, Stephane, Jin, Yu , Mahon, François‐Xavier , Hughes, Timothy P. , Shuvaev, Vasily , Ailawadhi, Sikander , Lipton, Jeffrey Howard , Turkina, Anna
Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 7054-7054
Treatment-Free Remission After Second-Line Nilotinib Treatment in Patients With Chronic Myeloid Leukemia in Chronic Phase
Mahon, François-Xavier, Boquimpani, Carla , Kim, Dong‐Wook , Benyamini, Noam , Clementino, Nelma Cristina D., Shuvaev, Vasily , Paz, Raquel de , Moiraghi, Beatriz, Nicolini, Franck E. , Dengler, Jolanta, Sacha, Tomasz , Takahashi, Naoto , Fellague-Chebra, Rafik, Acharya, Sandip, Wong, Stephane, Jin, Yu , Hughes, Timothy P. , Mahon, François Xavier, Ailawadhi, Sikander , Lipton, Jeffrey Howard , Turkina, Anna
Annals of Internal Medicine | February 19, 2018 | Volume: 168 | Issue: 7 | Pages: 461-470